Accelerate Diagnostics Inc reports results for the quarter ended in March - Earnings Summary

Accelerate Diagnostics

07/05/2021 19:31

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 41 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for a loss of 33 cents per share.
* Revenue rose 7.5% to $2.52 million from a year ago​;  analysts
expected $3.10 million.
* Accelerate Diagnostics Inc's reported EPS for the quarter was
a loss of 41 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Accelerate Diagnostics Inc shares had fallen by 12.3% this
quarter and lost 3.8% so far this year.
* The company reported a quarterly loss of $24.24 million.
* Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $12.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated May 7 at 06:31 p.m. GMT. ​All
figures in US Dollars.​